NILOTINIB Pharmacologic Class Indexing
- Class set ID
- 321ef947-5400-4ae0-9af0-7433eeffd3b3
- Version
- 3
- Effective date
- 20210723
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| NILOTINIB capsules, for oral use These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. Initial U.S. Approval: 2007 | AvKARE | 20260302 | 1 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. | 20251216 | 5 |
| These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation | 20251216 | 42 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20251120 | 1 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20251120 | 3 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | EXELAN PHARMACEUTICALS INC. | Cipla Limited | CIPLA LIMITED GOA | CIPLA LIMITED BOMMASANDRA | 20251114 | 1 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES . NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Dr. Reddy's Laboratories Inc | Dr. Reddy’s Laboratories Limited FTO-7 | 20251024 | 9 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Apotex Corp. | Apotex Inc. | 20250918 | 9 |
| These highlights do not include all the information needed to use DANZITEN safely and effectively. See full prescribing information for DANZITEN. DANZITEN (nilotinib) tablets, for oral use Initial U.S. Approval: 2007 | Azurity Pharmaceuticals, Inc. | 20250728 | 3 |
| These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 2007 | Cipla USA Inc. | Cipla Limited | CIPLA LIMITED GOA | CIPLA LIMITED BOMMASANDRA | Genvion Corporation | 20250702 | 5 |